Clinical Trial Update: A Pan-TB Regimen Targeting Host and Microbe [Phase 2, Phase 3]

View source ↗

Summary

A Pan-TB regimen targeting host and microbe is being evaluated in Phase 2 and Phase 3 trials for tuberculosis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: The Aurum Institute NPC | Conditions: Tuberculosis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING